Skip to main content

Acute Myeloid Leukemia (AML)

Advances in Acute Myeloid Leukemia (AML)

March 8, 2022

We invite you to learn more about:

  • Treatment advances for acute myeloid leukemia (AML)
  • Precision medicine for AML
  • The importance of clinical trials for AML
  • Side-effect management

Uma Borate, MD, MS
Associate Professor
Ohio State University
The James Comprehensive Cancer Center
Columbus, OH

Program Support

Support for this program is provided by Bristol-Myers Squibb; and Genentech, Inc. & Biogen.

See All Resources

White

Spotlight On Acute Myeloid Leukemia (AML)

April 26, 2023

We invite you to learn more about:

  • Improved therapies for AML
  • Clinical trials for AML
  • Side-effect management
  • Discussing quality of life issues with your treatment team

Roland B. Walter, MD, PhD, MS
Professor, Clinical Research Division
Fred Hutchinson Cancer Center
Professor, Medicine
Division of Hematology/Department of Laboratory
Adjunct Professor, Department of Laboratory
Medicine & Pathology
Adjunct Professor, Department of Epidemiology
University of Washington
Seattle, WA

Program Support

Support for this program is provided by AbbVie Inc. and Bristol Myers Squibb.

See All Resources

Spotlight On Acute Myeloid Leukemia (AML)
White

The Leukemia & Lymphoma Society (LLS) is now Blood Cancer United. Learn more.